Derek Hicks
Corporate Officer/Principal chez INTELLIA THERAPEUTICS, INC.
Fortune : 1 M $ au 30/04/2024
Postes actifs de Derek Hicks
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 20/12/2021 | - |
Historique de carrière de Derek Hicks
Anciens postes connus de Derek Hicks
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2020 | 01/12/2021 |
Formation de Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Bourse
- Insiders
- Derek Hicks
- Expérience
